LEADERSHIP IN NANOPHARMACEUTICALS - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 85085203
Serial Number
85085203
Word Mark
LEADERSHIP IN NANOPHARMACEUTICALS
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2014-03-17
Filing Date
2010-07-15
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2010-12-14
Attorney Name
David Ehrlich
Law Office Assigned Location Code
N10
Employee Name
EVANKO, PATRICIA MALES
Statements
Disclaimer with Predetermined Text
"NANOPHARMACEUTICALS"
Goods and Services
diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder
Goods and Services
Pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical
Goods and Services
Medical and scientific research services, namely, research, development, analytical, formulation, and product development services in the pharmaceutical field
Pseudo Mark
LEADERSHIP IN NANO PHARMACEUTICALS
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2010-07-20
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2010-07-20
Primary Code
005
Correspondences
Name
DAVID EHRLICH
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Continuity Child85977444
Trademark Events
Event DateEvent Description
2010-07-19NEW APPLICATION ENTERED IN TRAM
2010-07-20NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2010-07-21NOTICE OF PSEUDO MARK MAILED
2010-10-28ASSIGNED TO EXAMINER
2010-10-28EXAMINERS AMENDMENT -WRITTEN
2010-10-28EXAMINER'S AMENDMENT ENTERED
2010-10-28APPROVED FOR PUB - PRINCIPAL REGISTER
2010-10-29EXAMINER'S AMENDMENT MAILED
2010-11-10ASSIGNED TO LIE
2010-11-10LAW OFFICE PUBLICATION REVIEW COMPLETED
2010-11-24NOTICE OF PUBLICATION
2010-12-14PUBLISHED FOR OPPOSITION
2011-02-08NOA MAILED - SOU REQUIRED FROM APPLICANT
2011-07-26TEAS EXTENSION RECEIVED
2011-07-26EXTENSION 1 FILED
2011-07-26EXTENSION 1 GRANTED
2011-07-28NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
2012-02-08TEAS EXTENSION RECEIVED
2012-03-02CASE ASSIGNED TO INTENT TO USE PARALEGAL
2012-02-08EXTENSION 2 FILED
2012-03-06EXTENSION 2 GRANTED
2012-03-07NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
2012-07-24TEAS EXTENSION RECEIVED
2012-07-24TEAS REQUEST TO DIVIDE RECEIVED
2012-07-24DIVISIONAL REQUEST RECEIVED
2012-09-04DIVISIONAL PROCESSING COMPLETE
2012-07-24EXTENSION 3 FILED
2012-09-04EXTENSION 3 GRANTED
2012-09-05CORRECTED NOA MAILED
2012-09-05NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
2013-01-10TEAS EXTENSION RECEIVED
2013-01-10EXTENSION 4 FILED
2013-01-29EXTENSION 4 GRANTED
2013-01-30NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
2013-07-09TEAS EXTENSION RECEIVED
2013-08-02CASE ASSIGNED TO INTENT TO USE PARALEGAL
2013-07-09EXTENSION 5 FILED
2013-08-08EXTENSION 5 GRANTED
2013-08-09NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
2014-03-17ABANDONMENT - NO USE STATEMENT FILED
2014-03-17ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED